Scenario Analysis

In a world where traditional valuation models often fail to capture the complexity of disruptive technologies or geopolitical shifts, scenario analysis offers a framework for navigating uncertainty. Instead of relying on a single forecast of the future, the method explores several alternative future scenarios.

This gives a more robust valuation that reflects not only the most likely development, but also the potential high and low outcomes. For AK1A Research Lab, this means an opportunity to avoid the common traps that arise when one locks oneself into a single, often overly optimistic, picture of the future.

The core of scenario analysis lies in systematically identifying the most critical uncertainty factors that can affect a company's future. These can be anything from regulatory changes and technological breakout moments to macroeconomic trends and consumer behaviors. By combining these uncertainty factors into logical and internally consistent scenarios, a spectrum of possible futures is created.

Each scenario is then analyzed separately with the help of financial models in order to determine a value. Finally, these scenarios are combined into a composite valuation, often with weights reflecting the probability of each scenario.

The process begins by identifying the most critical uncertainty axes that define the future of the specific sector or company. For a biotech company, these can be 'Regulatory approval' and 'Technical success in clinical studies'. These axes are then combined in order to create four distinct scenarios: 'Best case', 'Worst case', 'Brake case' and 'Base case'.

Each scenario is described in detail, including its impact on revenue forecasts, cost structure and financial ratios. Financial models are then built for each scenario, often with the help of the discounted cash flow method (DCF), where the assumptions are adjusted sharply depending on the character of the scenario.